Tower Research Capital LLC (Trc) Medicinova Inc Transaction History

Tower Research Capital LLC (Trc)

  • $3.53 Billion
  • Q2 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Medicinova Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,462 shares of MNOV stock, worth $4,465. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,462
Previous 3,228 7.25%
Holding current value
$4,465
Previous $4,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$1.2 - $1.56 $280 - $365
234 Added 7.25%
3,462 $4,000
Q1 2025

May 15, 2025
SELL
$1.46 - $2.16 $181 - $267
-124 Reduced 3.7%
3,228 $4,000
Q4 2024

Feb 13, 2025
BUY
$1.53 - $2.38 $1,577 - $2,453
1,031 Added 44.42%
3,352 $7,000
Q3 2024

Nov 14, 2024
SELL
$1.13 - $2.1 $4,755 - $8,836
-4,208 Reduced 64.45%
2,321 $4,000
Q2 2024

Aug 13, 2024
SELL
$1.28 - $1.57 $5,198 - $6,375
-4,061 Reduced 38.35%
6,529 $9,000
Q1 2024

May 15, 2024
BUY
$1.28 - $1.65 $3,139 - $4,047
2,453 Added 30.15%
10,590 $15,000
Q4 2023

Feb 13, 2024
SELL
$1.38 - $2.06 $1,577 - $2,354
-1,143 Reduced 12.32%
8,137 $12,000
Q3 2023

Nov 14, 2023
BUY
$2.01 - $2.6 $1,340 - $1,734
667 Added 7.74%
9,280 $19,000
Q2 2023

Aug 14, 2023
SELL
$2.09 - $2.43 $24,904 - $28,955
-11,916 Reduced 58.04%
8,613 $19,000
Q1 2023

May 09, 2023
SELL
$1.95 - $2.54 $30,476 - $39,697
-15,629 Reduced 43.22%
20,529 $44,000
Q4 2022

Feb 10, 2023
BUY
$1.97 - $2.66 $62,647 - $84,590
31,801 Added 729.88%
36,158 $74,000
Q3 2022

Nov 10, 2022
SELL
$2.1 - $2.6 $7,654 - $9,477
-3,645 Reduced 45.55%
4,357 $10,000
Q2 2022

Aug 15, 2022
BUY
$2.31 - $3.14 $8,103 - $11,015
3,508 Added 78.06%
8,002 $20,000
Q1 2022

May 12, 2022
BUY
$2.19 - $2.81 $9,265 - $11,889
4,231 Added 1608.75%
4,494 $12,000
Q4 2021

Feb 14, 2022
SELL
$2.61 - $4.42 $15,106 - $25,582
-5,788 Reduced 95.65%
263 $1,000
Q3 2021

Nov 15, 2021
SELL
$3.4 - $4.24 $6,184 - $7,712
-1,819 Reduced 23.11%
6,051 $23,000
Q2 2021

Aug 16, 2021
BUY
$3.76 - $5.14 $14,220 - $19,439
3,782 Added 92.51%
7,870 $34,000
Q1 2021

May 17, 2021
SELL
$4.81 - $8.74 $33,164 - $60,262
-6,895 Reduced 62.78%
4,088 $21,000
Q4 2020

Feb 16, 2021
SELL
$5.03 - $6.31 $163,867 - $205,567
-32,578 Reduced 74.79%
10,983 $58,000
Q3 2020

Nov 16, 2020
BUY
$4.67 - $11.0 $154,180 - $363,165
33,015 Added 313.06%
43,561 $228,000
Q2 2020

Aug 13, 2020
BUY
$3.06 - $7.06 $32,270 - $74,454
10,546 New
10,546 $57,000
Q1 2020

May 15, 2020
SELL
$2.9 - $6.97 $176 - $425
-61 Closed
0 $0
Q4 2019

Feb 07, 2020
SELL
$6.48 - $8.76 $35,685 - $48,241
-5,507 Reduced 98.9%
61 $0
Q3 2019

Nov 05, 2019
SELL
$7.7 - $10.42 $26,711 - $36,146
-3,469 Reduced 38.39%
5,568 $44,000
Q2 2019

Aug 13, 2019
BUY
$8.29 - $13.22 $31,377 - $50,037
3,785 Added 72.07%
9,037 $87,000
Q1 2019

May 14, 2019
BUY
$6.82 - $10.27 $6,356 - $9,571
932 Added 21.57%
5,252 $44,000
Q4 2018

Feb 14, 2019
BUY
$7.65 - $12.83 $32,566 - $54,617
4,257 Added 6757.14%
4,320 $36,000
Q3 2018

Nov 13, 2018
BUY
$7.06 - $12.49 $444 - $786
63 New
63 $1,000
Q2 2018

Aug 15, 2018
SELL
$7.96 - $13.23 $11,470 - $19,064
-1,441 Closed
0 $0
Q1 2018

May 15, 2018
SELL
$6.6 - $13.91 $4,283 - $9,027
-649 Reduced 31.05%
1,441 $15,000
Q4 2017

Feb 09, 2018
SELL
$5.89 - $7.21 $9,270 - $11,348
-1,574 Reduced 42.96%
2,090 $14,000
Q3 2017

Nov 14, 2017
BUY
$4.43 - $6.58 $16,231 - $24,109
3,664
3,664 $23,000

Others Institutions Holding MNOV

# of Institutions
22
Shares Held
5.08M
Call Options Held
0
Put Options Held
0
View Full List

About MEDICINOVA INC

MNOV Quotes by TradingView
  • Ticker MNOV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,046,200
  • Market Cap $63.3M
  • Description
  • MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...
More about MNOV
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email